Results 1 to 10 of about 174,449,283 (168)

Accuracy of the postnatal growth and retinopathy of prematurity screening criteria in predicting prethreshold retinopathy of prematurity in the tertiary hospital, Bangkok, Thailand [PDF]

open access: yesTaiwan Journal of Ophthalmology, 2023
PURPOSE: The postnatal growth and retinopathy of prematurity (G-ROP), retinopathy of prematurity (ROP) predictive model, was developed in North America with high sensitivity and fewer infants examined.
Chavisa Bunyavee, Kornwipa Hemarat
doaj   +5 more sources

Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes [PDF]

open access: yesIndian Journal of Ophthalmology, 2011
Aim : The aim was to study the structural sequelae and refractive outcome after laser treatment for Type 1 prethreshold retinopathy of prematurity (ROP) in Asian Indian eyes.
Deeksha Katoch   +4 more
doaj   +5 more sources

Large spot transpupillary thermotherapy: A quicker laser for treatment of high risk prethreshold retinopathy of prematurity - A randomized study [PDF]

open access: yesIndian Journal of Ophthalmology, 2011
To compare structural and functional outcome and time efficiency between standard spot sized conventional pulsed mode diode laser and continuous mode large spot transpupillary thermotherapy (LS TTT) for treatment of high risk prethreshold retinopathy of ...
Shah Parag, Narendran V, Kalpana N
doaj   +5 more sources

Transscleral Diode Laser Photocoagulation for Type 1 Prethreshold Retinopathy of Prematurity [PDF]

open access: yesJournal of Ophthalmic & Vision Research, 2013
Purpose: To report the outcomes of transscleral diode laser photocoagulation for treatment of type 1 prethreshold retinopathy of prematurity (ROP). Methods: In this prospective interventional case series, 139 eyes of 73 infants with type 1 prethreshold ...
Mohammad Mehdi Parvaresh   +4 more
doaj   +4 more sources

Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II [PDF]

open access: yesBMC Pediatrics
Purpose The treatment with anti-VEGF for Retinopathy of prematurity (ROP) has already been widely applied in clinics even though there are still many concerns about this treatment.
Xiu-Mei Yang   +3 more
doaj   +4 more sources

Comparative Efficacy and Safety of Biosimilar Bevacizumab (Stivant®) versus Reference Product (Avastin®) in Prethreshold Type I Retinopathy of Prematurity [PDF]

open access: yesJournal of Current Ophthalmology
Purpose: To compare the efficacy and safety of Stivant® (biosimilar bevacizumab, CinnaGen, Iran) to Avastin® (innovator bevacizumab, Genentech, South San Francisco, CA) in premature infants with prethreshold type I retinopathy of prematurity (ROP ...
Mojtaba Abrishami   +8 more
doaj   +4 more sources

Posterior to the ridge laser in zone 2 stage 3 retinopathy of prematurity with plus disease: Efficacy and safety [PDF]

open access: yesIndian Journal of Ophthalmology, 2023
Purpose: This study aimed to ascertain the efficacy and safety of an additional posterior to the ridge laser for treatable zone 2 stage 3 retinopathy of prematurity (ROP).
Gaurav Sanghi   +2 more
doaj   +2 more sources

Topical Fasudil in Type 2 Retinopathy of Prematurity: A Pilot Study [PDF]

open access: yesJournal of Current Ophthalmology
Purpose: To evaluate the safety and effectiveness of topical fasudil drop, as a Rho kinase (ROCK) inhibitor agent, on type 2 retinopathy of prematurity (ROP). Methods: This comparative case series included 42 eyes of 21 premature infants with type 2 ROP.
Alireza Ramezani   +8 more
doaj   +2 more sources

Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity [PDF]

open access: yesEuropean Journal of Medical Research
Background To evaluate the effect and factors associated with the reactivation of retinopathy of prematurity (ROP) after intravitreal conbercept or aflibercept.
Chunling Huang   +10 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy